Gemfibrozil
Gemfibrozil is a prescription medication that helps lower high levels of cholesterol and triglycerides in the blood, reducing the risk of heart disease. It comes as 600mg oral tablets, manufactured by Zydus Lifesciences Limited under application ANDA204189. Note: This product is discontinued. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Gemfibrozil is a prescription medication that helps lower high levels of cholesterol and triglycerides in the blood, reducing the risk of heart disease. It comes as 600mg oral tablets, manufactured by Zydus Lifesciences Limited under application ANDA204189. Note: This product is discontinued. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Gemfibrozil",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Gemfibrozil — ANDA 203266 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203266"
}
]
|
| identifier | ANDA203266 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"health-care",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Gemfibrozil |
